Acadia Healthcare Company Downgraded to Neutral at Zacks (ACHC)
Acadia Healthcare Company (NASDAQ:ACHC) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a research report issued on Tuesday. They currently have a $53.00 target price on the stock. Zacks‘s target price would suggest a potential upside of 11.37% from the stock’s previous close.
In other Acadia Healthcare Company news, EVP Christopher L. Howard sold 1,156 shares of the stock in a transaction that occurred on Tuesday, July 29th. The shares were sold at an average price of $51.01, for a total transaction of $58,967.56. The transaction was disclosed in a filing with the SEC, which is available at this link.
Acadia Healthcare Company (NASDAQ:ACHC) traded down 0.63% during mid-day trading on Tuesday, hitting $47.59. 256,730 shares of the company’s stock traded hands. Acadia Healthcare Company has a 1-year low of $36.65 and a 1-year high of $53.87. The stock has a 50-day moving average of $46.86 and a 200-day moving average of $46.37. The company has a market cap of $2.847 billion and a P/E ratio of 39.38.
Acadia Healthcare Company (NASDAQ:ACHC) last announced its earnings results on Tuesday, July 29th. The company reported $0.32 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.31 by $0.01. The company had revenue of $213.80 million for the quarter, compared to the consensus estimate of $207.73 million. During the same quarter in the prior year, the company posted $0.26 earnings per share. The company’s quarterly revenue was up 20.5% on a year-over-year basis. Analysts expect that Acadia Healthcare Company will post $1.46 EPS for the current fiscal year.
ACHC has been the subject of a number of other recent research reports. Analysts at RBC Capital raised their price target on shares of Acadia Healthcare Company from $54.00 to $58.00 in a research note on Friday. Separately, analysts at Cantor Fitzgerald raised their price target on shares of Acadia Healthcare Company from $57.00 to $60.00 in a research note on Thursday, July 31st. They now have a “buy” rating on the stock. Finally, analysts at Raymond James reiterated an “outperform” rating on shares of Acadia Healthcare Company in a research note on Wednesday, June 4th. They now have a $55.00 price target on the stock, up previously from $49.00. Five research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $53.57.
Acadia Healthcare Company, Inc is a provider of inpatient behavioral healthcare services in the United States.
To view Zacks’ full report, visit Zacks’ official website.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.